Methodical Manipulation of the TME in Ovarian Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37939000.
- Also identified by DOI 10.1158/1078-0432.CCR-23-2365.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The complex interplay between ovarian cancer cells and the tumor microenvironment (TME) modulates progression, with dynamic cellular interactions influenced by external modulators, including neoadjuvant chemotherapy (NACT). A recent article described the alterations within the TME following NACT, either with or without bevacizumab, in ovarian cancer. See related article by Tavira et al., p. 176.
Medical subject headings
- Tumor Microenvironment
- Ovarian Neoplasms